Moneycontrol PRO
HomeNewsTarsonsproducts

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Trade Spotlight: How should you trade Relaxo Footwears, Chennai Petroleum, Transrail Lighting, CCL Products, Marksans Pharma, Titan, and others on July 7?

    Consolidation is expected to continue in the upcoming sessions, with resistance and support at last week's high-low. Below are some short-term trading ideas to consider.

  • Trade Spotlight: How should you trade Siemens, Torrent Pharma, Data Patterns, CAMS, PB Fintech, LTIMindtree, and others on Wednesday?

    The benchmark indices are expected to consolidate in the upcoming sessions and look for fresh triggers. Below are some trading ideas for the near term.

  • Trade Spotlight: How should you trade Bajaj Healthcare, TCS, HCL Tech, ICICI Lombard, Havells, Federal Bank, and others on Friday?

    According to experts, the Nifty 50 is likely to march towards the 24,300-24,500 zone if it manages to hold above 24,100 in the coming sessions. However, breaking below 24,100 could drag it down towards the 24,000-23,900 zone. Here are some trading ideas for the near term.

  • Your Nifty strategy for Diwali Muhurat trading, take positions in 10 stocks for Samvat 2080

    Viraj Vyas advises creating a non-directional spread in Nifty50 by selling 1 lot of 19,100PE and 1 lot of 19,500CE.

  • These 10 stocks moved between 10-35%: Do you own any?

    Volatility index (India VIX) was up 3.2 percent this week. The BSE largecap index rose 0.69 percent, midcap gained 0.36 percent, while smallcap was down 1.27 percent

  • Buy or sell: Top stock trading ideas by market experts which are good short term bets

    Rajesh Agarwal of AUM Capital recommends buying Hindustan Oil Exploration with stop loss at Rs 140 and target of Rs 149, Marksans Pharma with stop loss at Rs 31 and target of Rs 37 and Liberty Shoes with stop loss at Rs 206 and target of Rs 233.

  • Hold Marksans Pharma, says Sharmila Joshi

    Sharmila Joshi of sharmilajoshi.com is of the view that one may hold Marksans Pharma.

  • 5 stocks where brokerages retained buy post Q2 results can give up to 30% upside

    The pharma companies have posted mix earnings in the quarter ended September 2017 on the back pricing pressure and increased competition.

  • Sensex rebounds but is still down 1K points since Nov 7; 10 stocks which slipped up to 25%

    Analysts were expecting some sort of bounce back which has come considering the fact benchmark indices were trading near crucial support levels.

  • Prefer Glenmark Pharma, Sun Pharmaceutical, Lupin: Sharmila Joshi

    Sharmila Joshi of sharmilajoshi.com is of the view that is of the view that one may prefer Glenmark Pharma, Sun Pharmaceutical and Lupin.

  • Marksans Pharma may test Rs 48: Rajat Bose

    Rajat Bose of rajatkbose.com feels that Marksans Pharma may test Rs 48.

  • Buy Power Grid, says Sandeep Wagle

    Sandeep Wagle of powermywealth.com is of the view that one can buy Power Grid..

  • Buy Power Grid, advises Rajesh Agarwal

    Rajesh Agarwal of AUM Capital suggests buying Power Grid.

  • Prefer Sun Pharmaceutical Industries, says Vijay Chopra

    Vijay Chopra of enochventures.com is of the view that one may prefer Sun Pharmaceutical Industries.

  • Buy Grasim Industries, Petronet LNG, Marksans Pharma: Mitessh Thakkar

    Mitessh Thakkar of miteshthacker.com is of the view that one can buy Grasim Industries and Petronet LNG.

  • Prefer Cipla, Aurobindo Pharma: Gaurang Shah

    According to Gaurang Shah of Geojit Financial Services, one may prefer Cipla and Aurobindo Pharma.

  • Marksans to outperform on successful Goa unit inspection: IDFC

    Marksans Pharma, on February 20, announced that it has successfully completed UK MHRA inspection for its Goa facility without any critical observations. The company is now awaiting further instruction from the agency on the way forward

  • Buy Marksans Pharma, Pidilite Industries: Mitessh Thakkar

    Mitessh Thakkar of miteshthacker.com recommends buying Marksans Pharma and Pidilite Industries.

  • Bull's Eye: Buy Apollo Tyres, JSW Steel, SREI Infra, Ceat

    Sameet Chavan of Angel Broking is of the view that one may buy JSW Steel with a target of Rs 1750.

  • Stay invested in Marksans Pharma, says Rajat Bose

    Rajat Bose of rajatkbose.com is of the view that one may stay invested in Marksans Pharma.

  • Positive on Marksans Pharma, says Sharmila Joshi

    Sharmila Joshi of sharmilajoshi.com is positive on Marksans Pharma.

  • Buy Bharti Infratel, M&M Financial, Capital First: Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one may buy Bharti Infratel, Mahindra & Mahindra Financial Services, Nahar Spinning and Capital First.

  • Buy Marksans Pharma, IRB Infra; sell HUL, Hexaware: Thacker

    Mitesh Thacker of miteshthacker.com is of the view that one can buy Marksans Pharma and IRB Infra and sell Hindustan Unilever and Hexaware Technologies.

  • Stay invested in pharma space: Sharmila Joshi

    Sharmila Joshi of sharmilajoshi.com is of the view that one may stay invested in pharma space with long term view.

  • Exit Marksans Pharma, says Rajat Bose

    Rajat Bose of rajatkbose.com suggests exiting Marksans Pharma.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347